YJ:NASDAQYunji Inc. - American Depository Shares Analysis
Data as of 2026-08-10 - not real-time
$2.19
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Yunji Inc. is priced at $2.19 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has gained 48.0%. Relative strength is 59.0 — neutral — and the MACD signal is bullish. Recent trading has carved out support near $1.18 and resistance around $13.97.
Valuation screens as fair, on a P/E of 21.9 with no clean sector comparison available. Revenue is contracting at 18.3% on a -42.0% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 334.3%, a beta of 0.15 and a maximum drawdown of 51.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — hold in the near term, sell further out, at 4/10 long-term conviction.
Valuation screens as fair, on a P/E of 21.9 with no clean sector comparison available. Revenue is contracting at 18.3% on a -42.0% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 334.3%, a beta of 0.15 and a maximum drawdown of 51.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — hold in the near term, sell further out, at 4/10 long-term conviction.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading above the 200-day average of 1.57
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading above the 200-day average of 1.57
- 30-day volatility of 334.3%
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Negative profit margin of -42.0%
- Negative return on equity of -13.2%
- Revenue contracting at -18.3%
Key Metrics & Analysis
Financial Health
Revenue Growth-18.30%
Profit Margin-42.04%
P/E Ratio21.9
ROE-13.24%
ROA-7.00%
Debt/Equity4.61
P/B Ratio0.1
Op. Cash Flow$-57780000
Free Cash Flow$-58914124
Technical Analysis
TrendBearish
RSI59.0
Support$1.18
Resistance$13.97
MA 20$1.47
MA 50$1.51
MA 200$1.57
MACDBullish
VolumeIncreasing
Fear & Greed Index94.21
Valuation
GradeFair
TypeBlend
Risk Assessment
Beta0.15
Volatility334.28%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.